Abercrombie & Fitch

Abercrombie & Fitch raises forecasts as revival continues, chairman Maritnez to step down

Executive chairman Arthur Martinez announced he will step down at the end of this fiscal year, February 3

Abercrombie & Fitch
Sales are up for consecutive quarters

Abercrombie & Fitch Co’s (NYSE:ANF) revival continued as the trendy fashion chain upped forecasts for sales after good performances at both the core brand and Hollister.

Just days after the group launched its first ever gender-neutral range of children’s clothes, A&F now expects comparable sales in the final quarter to grow by high-single digits, against low-single digits forecast previously.

READ: Abercrombie & Fitch shares surge premarket after market beating third quarter results

A 53rd week in the trading year and currency changes will mean net sales will now show a low-teen percentage gain, again better than predicted before, though the increased sales volumes will mean expenses will rise slightly from last year’s $553.7mln.

Gross margins will be in line with the previous guidance, though US tax changes will mean a significant income tax charge.

Fran Horowitz, chief executive, said: "We are pleased by our performance across all brands and channels during the holiday season, with continued strength at Hollister, and the Abercrombie brand on track to deliver positive comparable sales for the quarter.”

Executive chairman Arthur Martinez also announced he will step down at the end of this fiscal year, February 3.

Martinez joined the board in January 2014 and took over as executive chairman in December of that year when A&F was struggling badly.

READ: Abercrombie & Fitch shares tumble after JPMorgan downgrades retailer

Fran Horowitz, though was appointed as chief executive last year and Martinez said he was proud of the progress the company was making under Horowitz’s leadership.

Terry Burman, lead independent director, will become non-executive chairman when Martinez steps down.

Quick facts: Abercrombie & Fitch

Price: $15.63

Market: NYSE
Market Cap: $1.03 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

1 day, 13 hours ago

2 min read